News

As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...
U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...
The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include ...
Myocarditis, when the heart muscle gets inflamed, can make it harder for the heart to pump blood possibly causing chest pain, ...
Discover the latest FDA warning updates for COVID vaccines including increased health risks and new restrictions for healthy ...
The FDA has approved its requested updated versions of expanded warning labels for COVID-19 vaccines. As Healio previously ...
The FDA has issued warnings regarding potential cardiac risks, specifically myocarditis and pericarditis, associated with the ...
Under the FDA’s new framework, it will no longer recommend the COVID vaccine for healthy people between the ages of 6 months and 64 years old.
Moderna has announced the FDA approval of a new, lower-dose messenger RNA (mRNA) vaccine against COVID-19, called mNEXSPIKE (mRNA-1283) (1).The product joins Moderna’s original COVID vaccine, Spikevax ...
June 2, 2025 -- The FDA has approved Moderna's new COVID-19 shot, an mRNA vaccine, with some limits on who can get it. The vaccine, called mNexspike, is for people who’ve previously received a ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.. The new vaccine is indicated for active immunization to prevent COVID-19 caused ...